Please select the option that best describes you:

When do you stop trying to eradicate an acquired factor VIII inhibitor?  

Patient with high titer acquired FVIII inhibitor with no causative etiology.  Bleeding is well-controlled on emicizumab, but inhibitor has failed to respond to corticosteroids, rituximab, cyclophosphamide, and mycophenolate.  With bleeding controlled, she is now developing more problems from immunosuppressive therapy than from the inhibitor.



Answer from: at Community Practice

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Community Practice